David-Alexandre C. Gros
Chief Executive Officer at ELEDON PHARMACEUTICALS, INC.
Net worth: 18 540 $ as of 2024-03-30
Profile
David-Alexandre C.
Gros was the founder of Imbria Pharmaceuticals, Inc. founded in 2018, where he held the title of Chairman & Chief Executive Officer.
He is also the founder of Eliem Therapeutics, Inc. Dr. Gros's current job is as Chief Executive Officer & Director at Eledon Pharmaceuticals, Inc. where he started in 2020.
Dr. Gros's former jobs include President, Chief Operating & Financial Officer at Neurocrine Biosciences, Inc. in 2017, Chief Strategy Officer & Executive Vice President at Sanofi from 2013 to 2015, Associate Principal at McKinsey & Co., Inc. from 2002 to 2006, Member-Supervisory Board at Saint Jean Groupe SA, Chief Financial Officer at Alnylam Pharmaceuticals, Inc. from 2016 to 2017, and Principal at Centerview Partners LLC from 2009 to 2011.
He also held the title of Chief Strategy Officer at Sanofi SA. Dr. Gros's education history includes an undergraduate degree from Dartmouth College in 1995, an MBA degree from Harvard Business School in 2002, and a doctorate degree from The Johns Hopkins University School of Medicine in 1999.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2023-04-30 | 9,000 ( 0.04% ) | 18 540 $ | 2024-03-30 |
David-Alexandre C. Gros active positions
| Companies | Position | Start |
|---|---|---|
| ELEDON PHARMACEUTICALS, INC. | Chief Executive Officer | 2020-09-08 |
Former positions of David-Alexandre C. Gros
| Companies | Position | End |
|---|---|---|
| NEUROCRINE BIOSCIENCES, INC. | President | 2017-12-30 |
| ALNYLAM PHARMACEUTICALS, INC. | Director of Finance/CFO | 2017-01-05 |
| SAINT JEAN GROUPE | Director/Board Member | 2015-12-30 |
| SANOFI | Corporate Officer/Principal | 2015-05-31 |
Centerview Partners LLC
 Centerview Partners LLC Investment Banks/BrokersFinance Centerview Partners LLC is a registered broker/dealer headquartered in New York City. The firm was founded by Robert Pruzan in 2006 and is a subsidiary of Centerview Partners Advisory Holdings LLC. Centerview Partners provides brokerage services to companies, institutions and governments. | Corporate Officer/Principal | 2010-12-31 |
Training of David-Alexandre C. Gros
| Dartmouth College | Undergraduate Degree |
| Harvard Business School | Masters Business Admin |
| The Johns Hopkins University School of Medicine | Doctorate Degree |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 6 |
|---|---|
| NEUROCRINE BIOSCIENCES, INC. | Health Technology |
| SANOFI | Health Technology |
| SAINT JEAN GROUPE | Consumer Non-Durables |
| ALNYLAM PHARMACEUTICALS, INC. | Health Technology |
| ELEDON PHARMACEUTICALS, INC. | Health Technology |
| ELIEM THERAPEUTICS, INC. | Health Technology |
| Private companies | 4 |
|---|---|
McKinsey & Co., Inc.
 McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services McKinsey & Co., Inc. provides management consulting services. It specializes in design, marketing and sales, analytics, operations, transformation and restructuring, risk, strategy and corporate finance, and sustainability and resource productivity. The company was founded by James O. McKinsey in 1926 and is headquartered in New York, NY. | Commercial Services |
Centerview Partners LLC
Centerview Partners LLC Investment Banks/BrokersFinance Centerview Partners LLC is a registered broker/dealer headquartered in New York City. The firm was founded by Robert Pruzan in 2006 and is a subsidiary of Centerview Partners Advisory Holdings LLC. Centerview Partners provides brokerage services to companies, institutions and governments. | Finance |
| Sanofi SA | Health Technology |
Imbria Pharmaceuticals, Inc.
 Imbria Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Imbria Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company developing novel therapies that restore cellular energy deficits. It focuses on restoring or improving the cell?s ability to produce energy where energy imbalances are at the root of disease, including cardiovascular diseases and inborn errors of metabolism. The company was founded by Andrew Levin and David-Alexandre C. Gros in 2018 and is headquartered in Boston, MA. | Health Technology |
- Stock Market
- Insiders
- David-Alexandre C. Gros
